Hennessy Capital Investment Corp. VII
NASDAQ:HVIIFinancial - Conglomerates
-$0.01 today
- Market cap
- $116.06M
- Beta
- 0.05
- P/E (TTM)
- 61.2
- EPS (TTM)
- $0.17
Volume 10.51M
Average 0.05M
HVII Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Hennessy Capital Investment Corp. VIINASDAQ: HVII
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 84.2% from a year ago
Cash & equivalents stood at $323.22K at the end of Q1 FY2026, down 84.2% from a year earlier and down 67.2% from the prior quarter.
Context
- Cash & equivalents amounted to 0.2% of total assets at the end of Q1 FY2026, down 0.9 pp from a year earlier.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -84.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 984.25K USD
- Year-over-year change
- +4820.0%
- 1-year CAGR
- +4820.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 984.25K | +4820.0% |
| FY2024 | 2024-12-31 | 20.01K | — |
Cash & Equivalents vs competitors
How HVII compares with its peers on the latest reported figures
- HVII's Mar 2026 cash & equivalents of $323.22K is the 5th highest of the 11 companies compared; the peer median is $122.01K.
- Its year-over-year change of -84.2% is the 8th highest of 10, against a peer median of -66.2%.
- Cash & equivalents amounts to 0.2% of total assets for HVII, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
OACCOaktree Acquisition Corp. III Life Sciences | Mar 2026 | $1.28M | -0.4% | — | 0.6% |
| Mar 2026 | $903.35K | — | — | 0.4% | |
BEAGBold Eagle Acquisition Corp. | Mar 2026 | $521.35K | +3295.5% | — | 0.2% |
| Mar 2026 | $412.91K | -66.2% | +95.5% | 0.2% | |
| Mar 2026 | $323.22K | -84.2% | — | 0.2% | |
POLEAndretti Acquisition Corp. II | Mar 2026 | $150.52K | -75.4% | — | 0.1% |
| Mar 2026 | $93.51K | -83.8% | — | 0.1% | |
| Mar 2026 | $56.4K | +1616.5% | — | 0.0% | |
DRDBRoman DBDR Acquisition Corp. II | Mar 2026 | $53.49K | -94.4% | — | 0.0% |
AACBArtius II Acquisition Inc. Class A Ordinary Shares | Mar 2026 | $20.3K | -94.3% | — | 0.0% |
| Mar 2026 | $14.89K | +1512.9% | — | 0.0% | |
| Peer median (excluding HVII) | $122.01K | -66.2% | +95.5% | 0.1% | |
Competitors are the stored peer set for HVII. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 20.01K | 984.25K |
| Short-term Investments | 0 | 0 |
| Net Receivables | 0 | 300K |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | 0 |
| Total Current Assets | 40.83K | 1.33M |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 0 | 196.96M |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 952.43K | 0 |
| Total Non-current Assets | 952.43K | 196.96M |
| Total Assets | 993.27K | 198.28M |
| Account Payables | 0 | 0 |
| Short-term Debt | 76.79K | 0 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 0 | 326.95K |
| Total Current Liabilities | 566.22K | 326.95K |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 450K | 0 |
| Other Non-current Liabilities | 0 | 10.05M |
| Total Non-current Liabilities | 450K | 10.05M |
| Total Liabilities | 1.02M | 10.38M |
| Common Stock | 671 | 196.96M |
| Retained Earnings | (47.95K) | (9.05M) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | (22.95K) | 187.91M |
| Total Debt | 76.79K | 0 |
| Net Debt | 56.79K | (984.25K) |
Hennessy Capital Investment Corp. VII
NASDAQ:HVII
Intrinsic Alpha fair value
Locked
Current Price
$4.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.